D. E. Shaw & Co., Inc. Amarin Corp Plcuk Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.66 - $0.91 $35,651 - $49,155	-54,017 Reduced 48.96%	56,302 $48,000
Q3 2023 Nov 14, 2023	SELL	$0.85 - $1.43 $96,856 - $162,947	-113,949 Reduced 50.81%	110,319 $101,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.49 $208,780 - $277,752	-186,411 Reduced 45.39%	224,268 $266,000
Q1 2023 May 15, 2023	SELL	$1.19 - $2.19 $974,024 - $1.79 Million	-818,508 Reduced 66.59%	410,679 $616,000
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $925,946 - $1.16 Million	865,371 Added 237.86%	1,229,187 $1.49 Million
Q3 2022 Nov 14, 2022	SELL	$1.09 - $1.67 $50,407 - $77,229	-46,245 Reduced 11.28%	363,816 $397,000
Q2 2022 Aug 15, 2022	SELL	$1.13 - $3.69 $1.33 Million - $4.33 Million	-1,174,412 Reduced 74.12%	410,061 $611,000
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $1.24 Million - $1.63 Million	436,642 Added 38.04%	1,584,473 $5.21 Million
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $3.47 Million - $5.55 Million	-1,070,959 Reduced 48.27%	1,147,831 $3.87 Million
Q3 2021 Nov 15, 2021	BUY	$3.94 - $5.84 $4.12 Million - $6.11 Million	1,046,256 Added 89.23%	2,218,790 $11.3 Million
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $5.83 Million - $8.89 Million	-1,367,797 Reduced 53.84%	1,172,534 $5.14 Million
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $6.6 Million - $11.5 Million	-1,311,661 Reduced 34.05%	2,540,331 $15.8 Million
Q4 2020 Feb 16, 2021	SELL	$4.04 - $5.31 $12.1 Million - $16 Million	-3,004,520 Reduced 43.82%	3,851,992 $18.8 Million
Q3 2020 Nov 16, 2020	BUY	$3.64 - $7.76 $4.21 Million - $8.99 Million	1,157,949 Added 20.32%	6,856,512 $28.9 Million
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $26.9 Million - $46.4 Million	5,620,863 Added 7234.06%	5,698,563 $39.4 Million
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $3.82 Million - $20.6 Million	-954,889 Reduced 92.48%	77,700 $311,000
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $12.3 Million - $21.3 Million	883,994 Added 594.9%	1,032,589 $22.1 Million
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $2.67 Million - $3.37 Million	-164,123 Reduced 52.48%	148,595 $2.88 Million
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $2.23 Million - $3.94 Million	176,455 Added 129.5%	312,718 $6.49 Million
Q4 2018 Feb 14, 2019	SELL	$12.41 - $22.98 $212,186 - $392,912	-17,098 Reduced 11.15%	136,263 $1.86 Million
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $168,199 - $1.12 Million	68,653 Added 81.05%	153,361 $2.5 Million
Q2 2018 Aug 14, 2018	BUY	$2.68 - $3.48 $67,742 - $87,963	25,277 Added 42.53%	84,708 $262,000
Q1 2018 May 15, 2018	SELL	$2.99 - $4.44 $76,627 - $113,788	-25,628 Reduced 30.13%	59,431 $179,000
Q4 2017 Feb 14, 2018	BUY	$3.06 - $4.09 $79,006 - $105,599	25,819 Added 43.58%	85,059 $341,000
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.72 $179,497 - $220,372	59,240	59,240 $207,000

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$12.4 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$6.21 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$1.65 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.27 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.25 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account